Kevin D Freeman insider trades: Galectin Therapeutics (GALT) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Kevin reports to the SEC
Open-market buys and sales
35 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 23, 2025 | GALT | ↑ Buy | 5,500 | $3.55 | $20K | Direct | Dec 23, 2025 (0d) |
| Jul 17, 2025 | GALT | ↑ Buy | 5,000 | $2.90 | $14K | Direct | Jul 18, 2025 (1d) |
| Dec 24, 2024 | GALT | ↑ Buy | 10,000 | $0.81 | $8K | Direct | Dec 26, 2024 (2d) |
| Oct 17, 2024 | GALT | ↑ Buy | 1,300 | $2.64 | $3K | Direct | Oct 17, 2024 (0d) |
| Oct 16, 2024 | GALT | ↑ Buy | 5,000 | $2.70 | $14K | Direct | Oct 16, 2024 (0d) |
| Oct 16, 2024 | GALT | ↑ Buy | 5,000 | $2.70 | $14K | By a limited liability company controlle | Oct 16, 2024 (0d) |
| Jun 20, 2024 | GALT | ↑ Buy | 2,500 | $2.38 | $6K | Direct | Jun 20, 2024 (0d) |
| Apr 22, 2024 | GALT | ↑ Buy | 2,500 | $2.98 | $7K | Direct | Apr 22, 2024 (0d) |
| Oct 28, 2022 | GALT | ↑ Buy | 10,000 | $1.41 | $14K | By a limited liability company controlle | Oct 31, 2022 (3d) |
| May 19, 2022 | GALT | ↑ Buy | 5,000 | $1.33 | $7K | By a limited liability company controlle | May 20, 2022 (1d) |
| Apr 18, 2022 | GALT | ↑ Buy | 5,000 | $1.71 | $9K | By a limited liability company controlle | Apr 18, 2022 (0d) |
| Jan 19, 2022 | GALT | ↑ Buy | 5,000 | $1.96 | $10K | By a limited liability company controlle | Jan 19, 2022 (0d) |
| Dec 6, 2021 | GALT | ↑ Buy | 5,000 | $2.28 | $11K | By a limited liability company controlle | Dec 15, 2021 (9d) |
| Dec 6, 2021 | GALT | ↑ Buy | 5,000 | $2.34 | $12K | By a limited liability company controlle | Dec 6, 2021 (0d) |
| Oct 29, 2021 | GALT | ↑ Buy | 2,000 | $3.17 | $6K | By a limited liability company controlle | Nov 1, 2021 (3d) |
| Oct 21, 2021 | GALT | ↑ Buy | 2,000 | $3.19 | $6K | By a limited liability company controlle | Oct 21, 2021 (0d) |
| Oct 19, 2021 | GALT | ↑ Buy | 3,000 | $3.37 | $10K | By a limited liability company controlle | Oct 19, 2021 (0d) |
| Sep 23, 2021 | GALT | ↑ Buy | 3,000 | $3.88 | $12K | By a limited liability company controlle | Sep 23, 2021 (0d) |
| Apr 5, 2021 | GALT | ↑ Buy | 5,000 | $2.04 | $10K | By a limited liability company controlle | Apr 6, 2021 (1d) |
| Sep 4, 2020 | GALT | ↑ Buy | 5,000 | $2.57 | $13K | By a limited liability company controlle | Sep 9, 2020 (5d) |
| Mar 19, 2020 | GALT | ↑ Buy | 6,000 | $1.64 | $10K | By a limited liability company controlle | Mar 20, 2020 (1d) |
| Nov 15, 2019 | GALT | ↑ Buy | 3,000 | $3.36 | $10K | By a limited liability company controlle | Nov 18, 2019 (3d) |
| Sep 6, 2019 | GALT | ↑ Buy | 1,290 | $3.71 | $5K | By a limited liability company wholly-ow | Sep 9, 2019 (3d) |
| May 31, 2019 | GALT | ↑ Buy | 7,710 | $4.28 | $33K | By a limited liability company wholly-ow | Jun 3, 2019 (3d) |
| May 31, 2019 | GALT | ↑ Buy | 1,426 | $4.28 | $6K | Direct | Jun 3, 2019 (3d) |
| Apr 5, 2019 | GALT | ↑ Buy | 500 | $4.73 | $2K | By a limited liability company wholly-ow | Apr 8, 2019 (3d) |
| Feb 8, 2019 | GALT | ↑ Buy | 1,500 | $4.29 | $6K | By a limited liability company wholly-ow | Feb 11, 2019 (3d) |
| Feb 1, 2018 | GALT | ↑ Buy | 2,000 | $4.10 | $8K | Ira | Feb 2, 2018 (1d) |
| Feb 1, 2018 | GALT | ↑ Buy | 2,000 | $4.10 | $8K | Ira | Feb 2, 2018 (1d) |
| Dec 7, 2017 | GALT | ↑ Buy | 8,000 | $1.63 | $13K | Ira | Dec 8, 2017 (1d) |
| Dec 7, 2017 | GALT | ↑ Buy | 400 | $1.64 | $657 | Direct | Dec 8, 2017 (1d) |
| Jun 1, 2015 | GALT | ↑ Buy | 2,083 | $2.70 | $6K | Ira | Jun 2, 2015 (1d) |
| Aug 15, 2014 | GALT | ↑ Buy | 1,000 | $4.70 | $5K | Direct | Aug 18, 2014 (3d) |
| Nov 18, 2013 | GALT | ↑ Buy | 1,000 | $6.08 | $6K | Direct | Nov 19, 2013 (1d) |
| May 28, 2013 | GALT | ↑ Buy | 1,000 | $4.21 | $4K | Direct | May 30, 2013 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other GALT insiders
Open-market trades in the last 12 months
About Kevin D Freeman's insider trades
Kevin D Freeman is an insider at Galectin Therapeutics (GALT). Since May 28, 2013, Kevin has reported 35 open-market purchases worth $329K and no sales on SEC Form 4. In the last 12 months: 1 buy ($20K).
Their filings also include grants and awards (13 filings), inherited shares (1 filing), other transactions (1 filing), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every GALT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.